Abiopharma

🔍 Peterson Justin (Executive)

Company: Tradeweb Markets Inc. (TW)

Report Date: 2026-03-17

Detailed Transactions and Holdings:

• Sold 1,241 shares of Class A common stock at $126.17 per share (Direct)
  Date: 2026-03-17 | Code: F | equity_swap_involved: 0 | shares_owned_after: 61,726.00 | transaction_form_type: 4 | Footnotes: F1, F2
• Acquired 3 shares of Class A common stock (Direct)
  Date: 2026-03-17 | Code: A | equity_swap_involved: 0 | shares_owned_after: 61,729.00 | transaction_form_type: 4 | Footnotes: F3, F2
• Sold 3,212 shares of Class A common stock at $124.7558 per share (Direct)
  Date: 2026-03-18 | Code: S | equity_swap_involved: 0 | shares_owned_after: 58,517.00 | transaction_form_type: 4 | Footnotes: F4, F5, F2

Footnotes:

• F1: Represents shares withheld by the issuer to satisfy the tax withholding obligation associated with the settlement of restricted stock units ("RSUs") in respect of the issuer's Class A common stock ("Class A Common Stock") held by the reporting person.
• F2: This amount includes (i) 2,548 unvested RSUs in respect of Class A Common Stock that are scheduled to vest on March 15, 2027, (ii) 4,485 unvested RSUs in respect of Class A Common Stock that are scheduled to vest in equal installments on March 17, 2027 and March 17, 2028 and (iii) 8,037 unvested RSUs in respect of Class A Common Stock that are scheduled to vest in equal installments on March 15, 2027, March 15, 2028 and March 15, 2029, in each case, subject to the reporting person's continued employment through the applicable vesting date.
• F3: Represents shares of Class A Common Stock acquired in connection with the settlement of certain dividend equivalent rights (the "DERs"). The DERs were granted in connection with previously awarded RSUs, and settled in shares of Class A Common Stock in connection with the settlement of the RSUs to which they relate.
• F4: This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 3, 2025.
• F5: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $123.32 to $125.86, inclusive. The reporting person undertakes to provide the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.